Clinical Trial

Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT

Study acronym: PERFECT-VR
Completed
View on ClinicalTrials.gov →
Summary
Lack of patient knowledge about ECT (electroconvulsive therapy) is a leading cause of treatment fear with 60% of ECT patients reporting high levels of anxiety. The purpose of this study is to determine if using Virtual Reality (VR) to allow patients' to experience a virtual ECT education session before treatment is useful in lowering treatment anxiety and increasing knowledge about ECT if compared to standard treatment. In addition, measuring heart rate and blood pressure levels before ECT treatment will allow us to assess changes in anxiety levels. Individuals who choose to participate will be placed (participant will have a 50% chance to be placed in either group) to view either a virtual reality video to experience a virtual ECT session, or to receive standard preparation, i.e. a discussion with a psychiatrist. Before and after this session participants will be asked to complete a measurement of their anxiety level and knowledge about ECT (ECT Attitude \& Knowledge Questionnaire). Just before ECT treatment, blood pressure, heart rate and anxiety level will be measured. Participants will also complete cognitive and depression assessments. This study will help to develop a relationship between healthcare providers and patients and their families to help with education before ECT treatment.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-14
notable Primary completion moved earlier: 2026-06 -> 2024-09-03 2026-08-14
minor Completion moved earlier: 2026-06 -> 2024-09-10 2026-08-14
Trial Details
NCT Number NCT04291196
Lead Sponsor Sunnybrook Health Sciences Centre
Conditions ECT, Electroconvulsive Therapy, Virtual Reality, Anxiety, Education, Hemodynamics, Depression, Cognition +1 more
Enrollment 66 participants
Start Date 2020-11-27
Primary Completion 2024-09-03 (estimated)
Study Completion 2024-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-08-13